VIDEO: Lucentis superior to PDT for treating myopic CNVM

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Nathan C. Steinle, MD, discusses the RADIANCE trial comparing Lucentis (ranibizumab, Genentech) vs. photodynamic therapy for myopic choroidal neovascular membrane.

Full Story →

VIDEO: Lucentis superior to PDT for treating myopic CNVM

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Nathan C. Steinle, MD, discusses the RADIANCE trial comparing Lucentis (ranibizumab, Genentech) vs. photodynamic therapy for myopic choroidal neovascular membrane.

Full Story →